These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3984660)

  • 1. Enhanced hypothalamic dopaminergic inhibition of LH, TSH and GH release in patients with pathological hyperprolactinaemia.
    Ho KY; Smythe GA; Lazarus L
    Acta Endocrinol (Copenh); 1985 Mar; 108(3):289-96. PubMed ID: 3984660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic control of gonadotrophin secretion in normal women and in patients with pathological hyperprolactinaemia.
    Ho KY; Smythe GA; Lazarus L
    Clin Endocrinol (Oxf); 1984 Jan; 20(1):53-63. PubMed ID: 6420095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of altered dopaminergic modulation of Prl, LH, FSH, GH and TSH secretion during chronic partial dopamine receptor blockade in normal women.
    Hagen C; Andersen AN; Djursing H
    Acta Endocrinol (Copenh); 1984 May; 106(1):1-7. PubMed ID: 6428112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of contraceptive steroids on hypothalamic-pituitary function.
    Mishell DR; Kletzky OA; Brenner PF; Roy S; Nicoloff J
    Am J Obstet Gynecol; 1977 May; 128(1):60-74. PubMed ID: 403765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in the control of prolactin, growth hormone and gonadotropin secretion in prepubertal rats.
    González LC; Pinilla L; Tena-Sempere M; Aguilar E
    J Endocrinol; 1999 Sep; 162(3):417-24. PubMed ID: 10467233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin and thyrotropin response to blockade of dopamine synthesis by monoiodotyrosine in subjects with postpartum and pathological hyperprolactinemia.
    Ghigo E; Ciccarelli E; Novelli A; Massobrio M; Müller EE; Camanni F
    J Endocrinol Invest; 1985 Feb; 8(1):35-40. PubMed ID: 3989236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of altered dopaminergic modulation of Prl, LH and TSH secretion in patients with normoprolactinaemic amenorrhoea.
    Hagen C; Petersen K; Djursing H; Andersen AN
    Acta Endocrinol (Copenh); 1984 May; 106(1):8-14. PubMed ID: 6428118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered dopaminergic regulation of thyrotrophin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function.
    Scanlon MF; Rodriguez-Arnao MD; McGregor AM; Weightman D; Lewis M; Cook DB; Gomez-Pan A; Hall R
    Clin Endocrinol (Oxf); 1981 Feb; 14(2):133-43. PubMed ID: 6790201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exaggerated circadian variation in basal thyrotropin (TSH) and in the dopaminergic inhibition of TSH release in pathological hyperprolactinemia: evidence against a hypothalamic dopaminergic defect.
    Rodriguez-Arnao MD; Peters JR; Foord SM; Dieguez C; Edwards C; Gomez-Pan A; Hall R; Newcombe RG; Scanlon MF
    J Clin Endocrinol Metab; 1983 Nov; 57(5):975-80. PubMed ID: 6619271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine affects basal and augmented pituitary hormone secretion.
    Leebaw WF; Lee LA; Woolf PD
    J Clin Endocrinol Metab; 1978 Sep; 47(3):480-7. PubMed ID: 122408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible altered dopaminergic modulation of pituitary function in normal-menstruating women with insulin dependent diabetes mellitus (IDDM).
    Djursing H; Carstensen L; Hagen C; Andersen AN
    Acta Endocrinol (Copenh); 1984 Dec; 107(4):450-5. PubMed ID: 6440390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin levels and the response to central dopamine synthesis blockade in subjects on oral contraceptives.
    Smythe GA; Ho K; Lazarus L
    IRCS J Med Sci; 1982 Feb; 10(2):124. PubMed ID: 12279213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prl, TSH, GH and LH responses to metoclopramide and breast-feeding in normal and hyperprolactinaemic women.
    Andersen AN; Tabor A
    Acta Endocrinol (Copenh); 1982 Jun; 100(2):177-83. PubMed ID: 7202316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced dopaminergic inhibition of thyrotrophin release in states of physiological hyperprolactinaemia.
    Rodriguez-Arnao MD; Weightman DR; Hall R; Scanlon MF; Camporro JM; Gomez-Pan A
    Clin Endocrinol (Oxf); 1982 Jul; 17(1):15-9. PubMed ID: 7116653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of oestrogens on the sensitivity of PRL, TSH and LH to the inhibitory actions of dopamine in hyperprolactinaemic patients.
    Valcavi R; Harris PE; Foord SM; Dieguez C; Evans PJ; Peters JR; Hall R; Scanlon MF
    Clin Endocrinol (Oxf); 1985 Aug; 23(2):139-46. PubMed ID: 4053412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin and TSH responses to both domperidone and TRH in normal and hyperprolactinaemic women after dopamine synthesis blockade.
    Ghigo E; Goffi S; Molinatti GM; Camanni F; Massara F
    Clin Endocrinol (Oxf); 1985 Aug; 23(2):155-60. PubMed ID: 3931942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reciprocal pattern of the TSH and PRL responses to dopamine receptor blockade in women with physiological or pathological hyperprolactinaemia.
    Massara F; Camanni F; Martra M; Dolfin GC; Müller EE; Molinatti GM
    Clin Endocrinol (Oxf); 1983 Feb; 18(2):103-10. PubMed ID: 6851194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of dopaminergic and antiserotoninergic drugs in the control of prolactin and LH release in normal women.
    Pontiroli AE; Alberetto M; Pellicciotta G; De Castro e Silva E; De Pasqua A; Girardi AM; Pozza G
    Acta Endocrinol (Copenh); 1980 Mar; 93(3):271-6. PubMed ID: 7376792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some aspects of hypothalamic-pituitary function in patients with anorexia nervosa.
    Travaglini P; Beck-Peccoz P; Ferrari C; Ambrosi B; Paracchi A; Severgnini A; Spada A; Faglia G
    Acta Endocrinol (Copenh); 1976 Feb; 81(2):252-62. PubMed ID: 813472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of altered dopaminergic modulation of prolactin and thyrotropin secretion in patients with polycystic ovary syndrome.
    Velardo A; Pantaleoni M; Zironi C; Zizzo G; Marrama P
    Horm Res; 1991; 35(1):4-7. PubMed ID: 1916652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.